Treatment of human promyeloleukemic HL-60 cells with the experimental antileukemic drug ajoene induces the activation of the mitogen-activated protein kinases (MAPKs) c-Jun NH 2 -terminal kinase (JNK), p38 and extracellular signal-regulated kinases (ERK) 1/2 as well as the survival kinase Akt. JNK activation occurred in HL-60/neo, HL-60/bcl-x L , and in HL-60 cells pretreated with the pan-caspase inhibitor zVAD-fmk, indicating that JNK activation is not dependent on ajoene-induced mitochondria perturbation and subsequent caspase activation. Cells overexpressing a dominant-negative JNK showed no altered sensitivity towards ajoene suggesting that the activation of JNK is not necessary for ajoeneinduced cell death. Inhibition of p38 MAPK by SB 203580 had no influence on ajoene-mediated apoptosis. In contrast, inhibition of ERK1/2 vastly enhanced ajoeneinduced cell death. The survival kinase Akt, in contrast, did not participate in ajoene-induced death signaling as shown by the use of the phosphatidylinositol-3-kinase inhibitor wortmannin. Thus in contrast to the previous findings regarding stress-induced cell death, ajoenemediated activation of JNK and p38 has no impact on ajoene-induced apoptosis in HL-60 cells. Blockade of ERK1/2 but not Akt pathways leads to sensitization of cells against ajoene-mediated apoptosis supporting the view that inhibition of ERK1/2 is a valuable strategy to increase the sensitivity of promyeloleukemic cells towards ajoene.
Introduction
Ajoene, an organosulfur compound originating from garlic (Agarwal, 1996) , has been shown to induce dose (5-40 mm)-and time (5-24 h)-dependent apoptosis in promyeloleukemic cells via the intrinsic pathway of apoptosis involving mitochondrial membrane permeabilization (MMP), the release of cytochrome c, and subsequent caspase activation (Dirsch et al., 1998 (Dirsch et al., , 2002 . Additionally, ajoene was demonstrated to initiate the generation of reactive oxygen species (ROS) independent of mitochondrial perturbation and upstream of caspase activation (Dirsch et al., 1998 (Dirsch et al., , 2002 . Ajoene-induced ROS production was shown to be linked to induction of apoptosis (Dirsch et al., 1998) raising the question as to what signaling events may lead from ROS generation to ajoene-mediated mitochondrial 'activation' and cell death.
ROS are recognized to play a key role in cell signaling, especially in pathways concerning cell proliferation and apoptosis (Hancock et al., 2001) . Activation of mitogen-activated protein kinases (MAPKs) is considered to be a pivotal step in ROS-induced signaling pathways. In fact, it has been shown that increased ROS production in leukemic cells leads to the activation of MAPKs and cell death (Chen et al., 1998; Shiah et al., 1999; Watabe et al., 1999; Zhuang et al., 2000) .
To date, three major MAPKs have been identified: the c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), the p38 MAPK, and the extracellular signal-regulated kinases (ERK) 1/2. ERK1/2 are mainly, but not exclusively, activated by growth factors and pivotally involved in mitogenesis (Chang and Karin, 2001) . JNK and p38, on the other hand, are activated by cellular stress and both have been associated with apoptosis (for review see Bamford et al., 2000) . Especially JNK was shown to be required for the mitochondria-dependent cell death pathway activated by a multitude of stress-inducing stimuli such as UV irradiation (Chen et al., 1996; Zanke et al., 1996; Butterfield et al., 1997; Tournier et al., 2000) . However, there are also reports that contradict an essential role of JNK in the mitochondrial apoptotic signaling pathway (Jarvis et al., 1999) . Similarly, activation of p38 seems to be involved in programmed cell death in a variety of cell types upon various apoptotic stimuli (Kummer et al., 1997; Mackay and Mochly-Rosen, 1999; Oh-hashi et al., 1999) . However, there are also reports that do not support this view (Zechner et al., 1998; MacFarlane et al., 2000) .
Thus, a general impact of JNK and p38 MAPK activation in apoptosis is still controversially discussed. This may be because of cell-type and cell-context specificity of apoptotic triggers and their subsequent signaling pathways.
ERK1/2 was shown to oppose the action of JNK/ SAPK (Xia et al., 1995; Gupta et al., 1999) . Inhibition of ERK1/2 by specific mitogen-activated extracellular kinase 1/2 (MEK1/2) inhibitors (PD 98059 and U 0126) resulted in an enhanced paclitaxel-induced apoptosis in solid tumor cell lines (MacKeigan et al., 2000) .
Protein kinase B (PKB)/Akt has been reported to be linked to apoptotic signaling. Akt inactivates the proapoptotic protein Bad (del Peso et al., 1997) and caspase-9, and stimulates the transcription factor NFkB (for review, see Datta et al., 1999) . Akt, thus, exerts antiapoptotic features.
As mentioned before, ajoene induces the intrinsic pathway of apoptosis involving the induction of ROS upstream of mitochondria-dependent caspase activation (Dirsch et al., 2002) . The aim of the present study was to clarify the participation of MAPKs and Akt in the apoptotic signaling of this organosulfur compound. First, we investigated whether MAPKs and Akt are activated in response to ajoene and second, whether the activation of these kinases is involved in ajoene-induced apoptotic cell death.
Results

Ajoene activates MAPKs and the survival kinase Akt
Incubation of HL-60 cells with ajoene (20 mm) leads to phosphorylation of JNK1 and JNK2 (Figure 1a, upper panel) . Activation of JNK1/2 occurs as late as 60 min and increases up to 300 min upon ajoene treatment. Figure 1b (upper panel) shows the time-dependent phosphorylation of p38 MAPK in HL-60 cells after stimulation with ajoene (20 mm). Phosphorylated p38 could be detected 5 min after ajoene addition and remained elevated up to 300 min. Interestingly, ERK1/ 2, a kinase suggested to play a role in survival pathways, is also phosphorylated upon exposure to ajoene. Figure 1c (upper panel) shows the time-dependent phosphorylation of ERK1/2 in HL-60 cells treated with ajoene (20 mm). ERK1/2 activation was observed 5 min after incubation with ajoene (20 mm) and quickly decreased after 30 min. Moreover, the survival kinase Akt is affected by ajoene. As demonstrated in Figure 1d (upper panel) phosphorylation of Akt occurs within the first 5 min after ajoene addition (20 mm). Maximal activation was reached after 15 min. Interestingly, etoposide (17 mm), a known activator of Akt (Tang et al., 2001) , did not elevate phospho-Akt levels until 2 h of incubation (Figure 1d ). Lower panels of Figures 1a-d show that protein levels of total JNK1/2, p38, ERK1/2 and Akt remain basically constant over time in response to ajoene (20 mm).
Dose-response studies (0.1-20 mm ajoene) revealed that phosphorylation of JNK and ERK1/2 occurred Etoposide (E; 17 mm) was applied as control (d) . In all, 40 mg protein per lane was separated by 7.5% (a-c) or 60 mg protein by 10% (d) SDS-PAGE. JNK-, p38-, ERK1/2-and Akt-phosphorylation as well as the respective total kinases were visualized using specific antibodies as described in Materials and methods already after stimulation with 0.5-1 mm ajoene, a concentration range that was shown not to result in apoptosis (data not shown) (Dirsch et al., 1998) . In contrast, p38 was phosphorylated not until 10 mm ajoene (data not shown), a dose that effectively induces apoptosis in HL-60 cells (Dirsch et al., 1998) .
Taken together, ajoene treatment of HL-60 cells leads to activation of JNK, p38, ERK1/2, and Akt following different kinetics (JNK, late and sustained; p38, fast and sustained; ERK and Akt, fast and transient). Next, we investigated the role of activated kinases in ajoeneinduced apoptosis.
Ajoene-induced JNK activation occurs independently of mitochondrial perturbation
Ajoene has been shown to induce inner and outer MMP within 4 h (Dirsch et al., 2002) , a time frame that seems to correlate with JNK activation (Figure 1a ). Therefore, we examined whether activation of JNK is a consequence of MMP or occurs independently of mitochondrial perturbation. Previous data have shown that cells overexpressing mitochondria-protecting Bcl-x L exhibit a significant reduced cell death rate in response to ajoene (Dirsch et al., 2002) . In contrast, ajoene-induced activation of JNK is not altered by Bcl-x L overexpression ( Figure 2a ). These data suggest that ajoenemediated JNK activation proceeds independently of the observed MMP (Dirsch et al., 2002) .
To examine whether active caspases are necessary for JNK activation, we employed the broad-spectrum caspase inhibitor zVAD-fmk (100 mm) (Figure 2b ). The pan-caspase inhibitor zVAD-fmk was unable to inhibit JNK activation but readily inhibited ajoene-induced caspase-3 activation (Figure 2c ), indicating that JNK activation occurs independent of caspase activation.
Taken together, these data suggest that JNK may act upstream of mitochondria-dependent caspase activation.
Relevance of JNK activation in ajoene-induced apoptosis
High concentrations of SB 203580 (100 mm) were shown to inhibit JNK activity (Lali et al., 2000; Eilers et al., 2001) . In fact, we found that ajoene-induced phosphorylation of JNK was inhibited by 100 mm SB 203580 ( Figure 3a , upper panel). SB 203580 treatment mainly resulted in a decreased phosphorylation of JNK2 (p57). This decrease in JNK activation, however, did not alter the rate of apoptosis induced by ajoene (20 mm, 6 h) ( Figure 3a , lower panel), suggesting lack of participation of JNK2 in this apoptotic process.
To strengthen this finding, we applied the new specific JNK inhibitor SP600125. This anthrapyrazolone inhibitor was shown to selectively inhibit JNK 1-3 (Bennett et al., 2001) . Employing the recommended concentration (0.1-10 mm), we found no impact of SP600125 on ajoene-induced apoptosis ( Figure 3b) .
Then, HL-60 cells constitutively overexpressing a dominant-negative JNK1 (HL-60/DN-JNK) were employed. The plasmid-encoding DN-JNK was hemagglutinin (HA)-tagged. Figure 3c shows the expression level of HA protein in control (HL-60/pcDNA3) and HL-60/ DN-JNK cells. Treating HL-60/DN-JNK with ajoene (20 mm) for 0-24 h, no significant difference in the apoptotic rate compared to control HL-60 cells could be observed (Figure 3d ). These data convincingly sum up that JNK is not required for the signaling leading to ajoene-induced apoptosis.
Activation of p38 MAPK is not involved in ajoene-induced apoptosis
Pretreatment of HL-60 cells with the specific p38 MAPK inhibitor SB 203580 (0.5-2 mm) did not alter the rate of JNK phosphorylation proceeds independent of active caspases. HL-60 cells were treated with ajoene (20 mm) for the indicated time periods (0-4 h) in the absence or presence (1 h preincubation) of the broad-spectrum caspase inhibitor zVAD-fmk (100 mm). A representative Western blot out of three is shown. (c) zVAD-fmk (100 mm) prevents ajoene-induced caspase-3 processing. HL-60 cells were either left untreated or were treated with zVAD-fmk (100 mm), ajoene (20 mm), or pretreated with zVAD-fmk (1 h, 100 mm) and then exposed to ajoene (20 mm) for 6 h. Caspase-3 and the cleavage product p17/p20 was detected by Western blot analysis using a specific antibody against caspase-3 ajoene (20 mm)-mediated apoptosis (Figure 4 ). SB 203580 itself (0.5-2 mm) had no influence on basal levels of apoptosis (Figure 4 ). When added after (10 min) or simultaneously with ajoene, SB 203580 also showed no significant effect (data not shown). These data suggest that activation of p38 MAPK is not involved in ajoeneinduced apoptosis.
Role of ERK1/2 in ajoene-induced apoptosis
ERK is considered to play a critical role in cell proliferation and cell growth. Nonetheless, ERK1/2 activation was found to accompany ajoene-triggered apoptosis (Figure 1c) . Therefore, we investigated a putative impact of ERK in the signal-transduction pathway leading to ajoene-mediated cell death. For this purpose, we used specific MEK1/2 inhibitors (U 0126 and PD 98059) in order to block the activation of ERK1/2. 0126 (10 mm) completely abolished ERK1/2 phosphorylation by ajoene (20 mm). Interestingly, blocking ERK 1/2 activation by MEK1/2 inhibition resulted in a tremendous enhancement of apoptosis compared to ajoene treatment alone. This effect, however, was not observed in leukemia Jurkat T cells. Ajoene induced apoptosis and activated ERK1/2 in Jurkat cells to a similar extent as in HL-60 cells. However, apoptosis was not amplified by the MEK1/2 inhibitors (data not shown). Thus, ajoene-induced ERK1/2 seems to act specifically in HL-60 cells as a survival factor. Specific inhibitors of ERK1/2 may, therefore, serve as sensitizers towards ajoene-mediated apoptosis in promyeloleukemic cells. These data were confirmed by a second MEK inhibitor (PD 98059) (Figure 5b ).
Role of Akt in ajoene-induced apoptosis
Akt, also termed protein kinase B (PKB), plays a major role in survival pathways. Ajoene activates Akt very rapidly as shown in Figure 1d . To examine a potential significance of Akt activation in ajoene-induced apoptosis, HL-60 cells were treated with ajoene (20 mm) in the absence or presence of the phosphatidylinositol-3-kinase (PI 3 K) inhibitor wortmannin (100 nm). Wortmannin abolished ajoene-induced Akt activation, confirming the necessity of PI 3 K activity for ajoene-induced Akt activation ( Figure 6a ). However, pre-as well as post-or simultaneous incubation with wortmannin neither enhanced nor decreased apoptosis in response to ajoene ( Figure 6b ). These data indicate that wortmanninsensitive and ajoene-mediated Akt activation does not participate in the observed apoptotic process.
Discussion
The present study shows that ajoene, an organosulfur compound that induces apoptosis in promyeloleukemic cells (Dirsch et al., 1998 (Dirsch et al., , 2002 , activates the MAPKs JNK, p38, and ERK1/2 as well as the survival kinase Akt, although by different kinetics. The main effort of this study was to elucidate the impact of these kinases in the apoptotic signaling induced by ajoene.
Role of JNK in ajoene-induced apoptotic signaling
There is a large body of evidence suggesting that persistent JNK activation induces cell death. The stimuli reported to induce JNK-dependent cell death are stress inducers such as UV-and g-irradiation (Chen et al., 1996; Zanke et al., 1996; Butterfield et al., 1997; Tournier et al., 2000) as well as cytotoxic drugs (Chen et al., 1999; Shiah et al., 1999 Shiah et al., , 2001 Watabe et al., 1999; Eichhorst et al., 2000; Mandlekar et al., 2000; SanchezPerez et al., 2000; Wang et al., 2000) and anticarcinogenic compounds such as isothiocyanates (Chen et al., 1998) . Thus, JNK has been suggested to be required for stress-induced mitochondrial death signaling pathways (Tournier et al., 2000) . In contrast, as shown here, the ajoene-mediated mitochondrial pathway of apoptosis does not require JNK activation. This finding is based on the following main experimental data: (1) In cells overexpressing Bcl-x L , JNK is activated equally compared to control (HL-60/neo) cells suggesting that JNK is activated independent of mitochondrial perturbation and cytochrome-c release. (2) The selective JNK inhibitor SP600125 did not influence ajoene-induced apoptosis. (3) HL-60 cells expressing a dominantnegative construct of JNK1 were equally sensitive in matters of apoptosis towards ajoene than control cells. Besides the results presented here for ajoene we found another study reporting that topoisomerase II inhibitors, such as etoposide, were shown to induce an apoptotic response in myeloid leukemia cells that is associated with recruitment of the JNK cascade but not dependent on JNK activation (Jarvis et al., 1999) . Thus, although most reports support the idea that JNK contributes to stress-induced apoptosis, the effect of JNK appears to depend on cell type and the context of other signals received by the cell (Herr and Debatin, 2001) . Chen et al. (1996) suggested that the duration of JNK activation may be a determining factor in the cellsignaling decision between cell proliferation versus cell death. Persistent JNK activation (>1-2 h) seems to be necessary to induce cell death. This, however, may not be the only requirement since ajoene induced a sustained JNK activation (5 h) in HL-60 cells, which does not lead to cell death. Chen et al. (1998) show that isothiocyanates, organosulfur compounds as ajoene, that induce sustained JNK activation also induce apoptosis in several cell types. As shown for ajoene, isothiocyanateactivated JNK occurs in the absence of active caspases. Furthermore, isothiocyanates seem to mediate their effects, as ajoene, by oxidative stress. In contrast to ajoene-induced apoptosis, isothiocyante-mediated cell death requires JNK activation and this JNK activation was decreased in Bcl-2-transfected cells implicating the antiapoptotic protein Bcl-2 as an upstream suppressor for JNK activation and subsequent apoptosis. Ajoeneactivated JNK was not influenced by overexpression of the antiapoptotic Bcl-2 family protein Bcl-x L . Thus, the source and kinetics of ROS generation may have an impact on the apoptotic signaling pathway and its requirement of JNK.
Role of 38 MAPK in apoptosis triggered by ajoene p38 MAPK activation was reported to be involved in apoptosis in a variety of cell types, induced by growth factor withdrawal (Kummer et al., 1997) , ischemia (Mackay and Mochly-Rosen, 1999) , and oxidative stress (Oh-hashi et al., 1999) . p38 MAPK was activated early after ajoene treatment (5 min) and activation was persistent up to 5 h. However, the p38 MAPK inhibitor SB 203580 did not attenuate apoptosis suggesting that activation of p38 is not required for ajoene-induced apoptosis. In contrast, for example, Galan et al. (2000) using a similar cell system (human promonocytic U 937 cells) showed that p38 MAPK is involved in cadmiuminduced apoptosis. Cadmium, however, led to H 2 O 2 generation and p38 phosphorylation as late as 30 min suggesting that the kinetics by which p38 is activated may be important for its impact on apoptosis.
Role of ERK1/2 and Akt in ajoene-mediated apoptotic signaling
Blocking the rapid and transient induction of ERK1/2 by ajoene using MEK inhibitors (U 0126, PD 98059) resulted in a vast enhancement of apoptosis. This observation is extremely interesting and in line with work published by MacKeigan et al. (2000) , examining the role of ERK in paclitaxel-treated tumor cells. ERK obviously is activated in response to ajoene as a counterbalancing survival factor. The observed amplification of ajoene-induced apoptosis in promyeloleukemic cells, however, does not seem to be necessarily transferrable to other leukemia cells. Jurkat T cells responded well towards ajoene in terms of apoptosis induction as well as activation of ERK. ERK1/2 inhibition in Jurkat cells, however, had no influence on ajoene-mediated apoptosis. One reason for this discrepancy might be that promyeloleukemic HL-60 cells differentiate in response to various stimuli, and this differentiation is coordinated with ERK activation (Yen et al., 1998) . Thus, inactivation of ERK may prevent differentiation of HL-60 cells and thus sensitizes promyeloleukemic cells towards cytotoxic drugs such as ajoene.
In this context, we addressed also a putative role for Akt, another kinase known to promote cell survival.
Our data show Akt activation during drug-induced apoptosis. Akt was reported to prevent cell death upstream of mitochondria, for example, by phosphorylating proapoptotic protein Bad (Datta et al., 1997; del Peso et al., 1997; Kennedy et al., 1999) . Thus, inhibition of Akt may also lead to an amplified apoptotic cell death. In fact, this has been shown for the two apoptosis-inducing compounds etoposide and staurosporine (STS) (Tang et al., 2001 ), but seems not to apply for ajoene sharing an intrinsic pathway of apoptosis with etoposide (Ibrado et al., 1996; Dirsch et al., 2002) and STS. However, time dependency of Akt activation differs between ajoene, etoposide, and STS: ajoene shows a rapid activation (5 min) followed by a fast decline. Both, etoposide and STS, lead to a persistent activation of Akt (Tang et al., 2001) . The differing time course of Akt activation by ajoene may point to a role different from a signaling 'brake' in apoptosis, as suggested by its activation by etoposide or STS (Tang et al., 2001) . Certainly, more work, such as the present study, is needed to elucidate a putative link between Akt activation and apoptosis induction via the intrinsic pathway by cytotoxic drugs.
In summary, our data show that the MAPKs JNK, p38, and ERK1/2 are activated during ajoene-induced apoptosis. Although JNK participates in mitochondriadependent pathways in different model systems, we show that JNK is not required for apoptosis induced by ajoene. The role of p38 in apoptosis is even more controversially discussed. Our data support the view that p38 is not an essential factor in ajoene-induced apoptosis. Thus, the need of activated JNK and/or p38 for the execution of apoptosis via cytochrome-c release seems to be highly stimulus-as well as cell-typedependent. Since JNK as well as p38 are not required for ajoene-induced apoptosis, they might serve other purposes, for instance, mediating differentiation signals. Stimulation of Akt by ajoene seems not to function as the known survival factor as does ajoene-activated ERK. This leads to speculations implying other functions for Akt besides its antiapoptotic properties.
Materials and methods
Cells and culture conditions
The human acute myeloid leukemia cell line HL-60 (DSM ACC 3, DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) and HL-60 cells transfected with the pSFFVneo-bcl-x L plasmid (HL-60/bclx L ) or pSFFV-neo plasmid (HL-60/neo) (a gift from Dr KN Bhalla, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA) were cultivated as described (Dirsch et al., 2002) . HL-60/DN-JNK were cultured in the presence of 100 U/ml penicillin, 100 mg/ml streptomycin, and G 418 (100 mg/ml). Ajoene ((E,Z)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide) was obtained from Lichtwer Pharma AG (Berlin, Germany) and dissolved in PBS. PD 98059, SB 203580, U 0126, SP600125, and the pancaspase inhibitor zVAD-fmk were obtained from CalbiochemNovabiochem (Bad Soden, Germany) and wortmannin from Alexis Biochemicals (Gru¨nberg, Germany). Substances were dissolved as recommended by the manufacturer.
Establishment of HL-60/DN-JNK clones
Transfection was performed by electroporation (model T800; BTX, San Diego, CA, USA) of HL-60 cells with the dominantnegative expression vector for JNK/SAPK (pSRa-APF). Briefly, cells were suspended in 1 ml of HEPES-buffered saline containing plasmid DNA and then received electric treatment as follows: electric amplitude, 400 V; pulse width, 99 ms. After 10 min on ice, the cells were transferred to fresh complete medium and cultured for 48 h before addition of G 418 500 mg/ml. The transfected cells were selected by G 418 for 4 weeks and all of the survival clones were pooled to avoid problems with clonal variation.
Quantification of apoptosis
The rate of apoptotic cell death was quantified by flowcytometric analysis of propidium iodide (PI)-stained nuclei according to Nicoletti et al. (1991) . After preincubation with PD 98059, SB 203580, SP600125, U 0126, wortmannin or the pan-caspase inhibitor zVAD-fmk for 1 h, cells were incubated with ajoene (20 mm) for the indicated time periods. Cells were collected by centrifugation (340 g) and apoptosis was detected as described previously (Dirsch et al., 2001) . As a further indication of cell death, we determined the ability of cells to exclude PI. Cells were incubated with PI (50 mg/ml in PBS) and cells staining PI-positive were quantified by flow cytometry (FACSCalibur with CELLQuest software, Becton Dickinson, Heidelberg, Germany).
Western blot analysis
Cells (1 Â 10 6 /ml) were incubated in the absence or presence of ajoene (20 mm) for various time periods as indicated, harvested by centrifugation and lysed immediately in 2 mm EDTA, 137 mm NaCl, 10% glycerol, 2 mm tetrasodiumpyrophosphate, 20 mm Tris, 1% Triton X-100, 20 mm natriumglycerophosphathydrat, 10 mm NaF, 2 mm natriumorthovanadate, 1 mm PMSF, supplemented with the protease inhibitor complete TM (Roche, Mannheim, Germany) for 15 min at 41C. Lysates were homogenized by a sonifier (five cycles) and centrifuged at 11 000 g for 10 min at 41C. Protein concentration of supernatants was measured by the Bradford method (Bradford, 1976) . Cell lysates, containing equal amounts of protein, were boiled in SDS-sample buffer for 5 min before loading on an SDS-polyacrylamide gel (7.5% for p38, ERK1/2, and JNK; 10% for Akt, HA). Proteins were transferred to polyvinylidene difluoride membranes (Immobilon-Pt, Millipore, Eschborn, Germany). Membranes were blocked with 5% fat-free dry milk in Tris-buffered saline (50 mm Tris pH 8.0, 150 mm NaCl) with 0.1% Tween 20 (TBS-T pH 8.0) and then incubated with specific antibodies against phospho-p38 (Thr 
Statistical analysis
All experiments were performed at least three times. Results are expressed as mean7s.e.m. Statistical analysis was performed by ANOVA followed by a Bonferroni's multiple comparison test or by an unpaired two-tailed Student's t-test. P values o0.05 were considered significant.
